Repros Therapeutics (RPRX)
0.295
-0.00 -0.47%
NASDAQ
Sep 26, 16:59
Delayed 2m
USD
View All Key Stats
RPRX Key Stats
| Income Statement | |
| Revenue (TTM) | 0.03M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.62 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -16.26M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -31.41K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 11.10M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 257.36 |
| PE Ratio (TTM) | -- |
| Price to Book Value | -- |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | -- |
| Free Cash Flow (Quarterly) | -1.979M |
| Return on Equity (TTM) | -309.7% |
View All RPRX News
RPRX News
-
WireHeadlineTime (ET)
-
Yahoo08/14 23:24
-
SA Breaking News08/14 09:19
-
Globe Newswire08/14 09:15
-
Yahoo08/01 16:59
-
Yahoo08/01 09:57
-
PR Newswire07/24 13:21
-
Yahoo07/24 13:21
-
Yahoo07/18 17:50
-
MT Newswires07/17 16:41
-
Yahoo07/17 16:17
View All Events
RPRX Events
| Date | Type | Description |
|---|---|---|
| 03/31/2017 | Earnings | Repros Therapeutics Inc Fourth Quarter Earnings Results in 2016 |
| 11/08/2016 14:30 CDT | Earnings | Repros Therapeutics Inc Third Quarter Earnings Results in 2016 |
RPRX Fundamentals
Income Statement View Statement
RPRX Ratings
Advertisement
RPRX One Page Reports
- One Page Report Download
RPRX Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Target Price | |
| Price | 0.295 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.reprosrx.com
- Investor Relations URL: http://ir.reprosrx.com/index.cfm
- HQ State/Province: Texas
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: Mar. 31, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Repros Therapeutics Inc is a development stage biopharmaceutical company. The Company is engaged in the development of new drugs to treat hormonal and reproductive system disorders.
RPRX Comparables
EditRPRX Excel Add-In Codes
- Name: =YCI("RPRX","name")
- Description: =YCI("RPRX","description")
- Sector: =YCI("RPRX","sector")
- Industry: =YCI("RPRX","industry")
- Est. Current Fiscal Year End: =YCI("RPRX","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other RPRX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- RPRX Tweets Stocktwits
Advertisement
